1. Home
  2. CVR vs PFSA Comparison

CVR vs PFSA Comparison

Compare CVR & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chicago Rivet & Machine Co.

CVR

Chicago Rivet & Machine Co.

HOLD

Current Price

$13.57

Market Cap

10.4M

Sector

Industrials

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$0.92

Market Cap

3.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVR
PFSA
Founded
1920
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
3.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CVR
PFSA
Price
$13.57
$0.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7K
241.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$26,986,627.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.15
$0.05
52 Week High
$15.00
$4.22

Technical Indicators

Market Signals
Indicator
CVR
PFSA
Relative Strength Index (RSI) 46.92 45.88
Support Level $13.32 $0.85
Resistance Level $14.47 $2.22
Average True Range (ATR) 0.51 0.13
MACD -0.02 -0.08
Stochastic Oscillator 18.29 16.98

Price Performance

Historical Comparison
CVR
PFSA

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: